First Time Loading...
L

Lepu Biopharma Co Ltd
HKEX:2157

Watchlist Manager
Lepu Biopharma Co Ltd
HKEX:2157
Watchlist
Price: 6.41 HKD 3.55% Market Closed
Updated: May 5, 2024

Lepu Biopharma Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lepu Biopharma Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
Lepu Biopharma Co Ltd
HKEX:2157
Cash from Operating Activities
-¥480.9m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥7.8B
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
-¥1.7B
CAGR 3-Years
-78%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Operating Activities
¥1.5B
CAGR 3-Years
49%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Operating Activities
¥3.6B
CAGR 3-Years
3%
CAGR 5-Years
106%
CAGR 10-Years
47%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Operating Activities
¥1.2B
CAGR 3-Years
57%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Lepu Biopharma Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-480.9m CNY

Based on the financial report for Dec 31, 2023, Lepu Biopharma Co Ltd's Cash from Operating Activities amounts to -480.9m CNY.

What is Lepu Biopharma Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-4%

Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for Lepu Biopharma Co Ltd have been -4% over the past three years .